# Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

> **NCT00667472** · PHASE1 · WITHDRAWN · sponsor: **University of California, Irvine**

## Conditions studied

- Port-Wine Stain

## Interventions

- **DRUG:** Ranibizumab
- **DEVICE:** Pulsed Dye Laser

## Key facts

- **NCT ID:** NCT00667472
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-03
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled
- **Last updated:** 2022-11-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00667472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00667472, "Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00667472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*